M
Monte Rosa Therapeutics, Inc. (GLUE)
15.38
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
15.38
0.00 (0.00%)
This stock has a consensus price target of $22.00 based on the ratings of 7 analysts. The high is $37.00 and the low is $11.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 11 | $ 22 | $ 37 |
| O’zgarish | -28.48% | 43.04% | 140.57% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-03-18 | 95.06% | Guggenheim | $34 → $30 | Maintains | Buy |
| 2026-03-18 | 88.56% | Wells Fargo | $30 → $29 | Maintains | Overweight |
| 2026-01-14 | 140.57% | Piper Sandler | $27.5 → $37 | Reiterates | Overweight |
| 2026-01-08 | 95.06% | Wells Fargo | $22 → $30 | Maintains | Overweight |
| 2026-01-08 | 121.07% | Guggenheim | $16 → $34 | Maintains | Buy |